...
首页> 外文期刊>Cellular reprogramming >Advances in Understanding the Roles of Mesenchymal Stem Cells in Lung Cancer
【24h】

Advances in Understanding the Roles of Mesenchymal Stem Cells in Lung Cancer

机译:Advances in Understanding the Roles of Mesenchymal Stem Cells in Lung Cancer

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lung cancer is the most common and deadliest type of cancer worldwide. Research concerning lung cancer has made considerable progress in recent decades, but lung cancer remains the leading cause of malignancy-related mortality rate. Mesenchymal stem cells (MSCs) mainly exist in fat, umbilical cord blood, bone marrow, bone, and muscle. MSCs are a primary component of the tumor microenvironment (TME). Recent studies have shown that MSCs have roles in lung cancer-related proliferation, invasion, migration, and angiogenesis, but the underlying mechanisms are poorly understood. Because MSCs can migrate to the TME, there is increasing attention toward the use of MSCs in drugs or gene vectors for cancer treatment. This review summarizes the roles and effects of MSCs in lung cancer, while addressing clinical applications of MSCs in lung cancer treatment.
机译:肺癌是全世界最常见和最致命的癌症类型。近几十年来,有关肺癌的研究取得了长足的进展,但肺癌仍然是恶性肿瘤相关死亡率的主要原因。间充质干细胞(MSCs)主要存在于脂肪、脐带血、骨髓、骨骼和肌肉中。间充质干细胞是肿瘤微环境 (TME) 的主要组成部分。最近的研究表明,间充质干细胞在与肺癌相关的增殖、侵袭、迁移和血管生成中发挥作用,但其潜在机制知之甚少。由于间充质干细胞可以迁移到TME,因此人们越来越关注间充质干细胞在药物或基因载体中用于癌症治疗。本文总结了间充质干细胞在肺癌中的作用和作用,同时探讨了间充质干细胞在肺癌治疗中的临床应用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号